Genomic, epigenetic and proteomic biomarkers in psychosis: a translational approach including high- risk individuals, patients with schizophrenia and animal models: ERA-NET PROJECT (GEPI-BIOPSY) by Labad, Javier
Genomic, epigenetic and proteomic biomarkers in 
psychosis: a translational approach including high-








Under the umbrella of NEURON, a joint transnational call (JTC2019) 
is launched in the field of biomarkers in disorders of the brain. For 
the afflicted patients a correct diagnosis and individualized 
treatment without severe side effects are of crucial importance.
Aims… multinational, collaborative research projects that will 
address the unmet medical need for valid and reliable biomarkers 
for the diagnosis, patient stratification, prognosis, monitoring and 
prediction of treatment response and side effects in neurological 
and psychiatric diseases.
… promote multi-disciplinary work and translational research 
proposals that combine basic and clinical approaches. In the 
context of the present call, the inclusion of psychiatrists and/or 
neurologists in the postulating consortia is highly encouraged, 
along with fundamental neuroscientists. The consortia are 
expected to submit novel, ambitious ideas that can only be 
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Schizophrenia and psychotic disorders are prevalent conditions and constitute a major health burden
world-wide.
The research field has moved to studying people with prodromal symptoms (At Risk-Mental States or
Ultra-High-Risk).
Early detection is a promising approach for reducing
the duration of untreated psychosis and improving
the outcome
Clinical symptoms are not very good at predicting
who will develop a psychotic disorder
30-40% will develop a psychotic disorder
UHR research includes help-seeking individuals
(‘stressed’ – potential bias)
Recent interest in adding ‘omics’ biomarkers to the predictive value of psychosis transition in UHR
DNA methylation: methylation of gene promoters and pathways relevant for psychosis, including 
oxidative stress regulation, axon guidance and inflammatory pathways in those UHR with a psychotic 
transition (Kebir et al., 2017).
Other groups have also reported the utility of DNAm patterns for psychotic experencies during 
adolescence (ALSPAC Cohort) (Suderman et al., 2019).
Validation of a set of 26 biomarkers in plasma: AUC= 0.82 for transition to schizophrenia (Chan et al., 2015).
Polygenic risk scores cannot be used alone to predict psychosis transition (AUC= 0.59-0.65) (Chaumette et 
al.; Perkins et al., 2020).
Recent interest in proteomics for increasing prediction of psychosis in UHR (AUC= 0.96) (Mongan et al., 2020)
INTRODUCTION (II)
1. The combination of ‘omics’ and clinical data with machine learning might improve the diagnostic accuracy
2. Most longitudinal studies focused on dichotomic variables (psychotic transition) and help-seeking UHR
3. Better definition of phenotypes with a translational approach (use of animal models) might help to 
improve the detection of biomarkers that are important for the psychotic phenotype
THE MATERNAL IMMUNE ACTIVATION MODEL 
OF SCHIZOPHRENIA
Bergdolt & Dunaevsky, 2019
BEHAVIOURAL CHANGES IN THE OFFSPRING
Similar phenotype to the observed in people with
schizophrenia and ultra-high-risk populations:





BRAIN CHANGES IN THE OFFSPRING
Structural brain changes
Structural and functional neuronal impairments
IMMUNE ALTERATIONS AND EPIGENETIC 
CHANGES IN THE OFFSPRING
INTRODUCTION (III)






features (diagnosis) in 
humans
Relationship with behavioural
measures in both rats and 
humans
To study the correlation
between epigentics and 





And Local Ethics Committee
Written informed consent to 








Students complete an on-line questionnaire including three psychometric scales: 
CAPE-P15 (psychotic experiences), APRI (bullying), CBQ (cognitive biases)
Clinical staff from the Early Intervention Service from psychosis conduct informative
workshop on psychotic experiences the same day (after online questionnaire)
EPIDEMIOLOGICAL STEP: RECRUITMENT AT SCHOOLS
CLINICAL STUDY: RECRUITMENT AT PARC TAULÍ HOSPITAL
Selection of extreme phenotypes based on CAPE-15:
Low vs High psychotic-like experiences (PLE)
CAARMS administration for 3 groups (N= 50 each):
Healthy controls
CAPE -; CAARMS -
PLE without UHR
CAPE +; CAARMS -
UHR
CAPE +;  CAARMS +
1
SAMPLE OF PEOPLE WITH SCHIZOPHRENIA3
PsyCourse cohort of affective and non-affective psychosis patients 
and healthy controls. 
More than 1,600 participants (>1,300 patients and >300 controls) 
have been enrolled at 17 sites in Germany and Austria.
Already recruited
Extensive prospective phenotyping (2500 variables)
Blood/serum/plasma available (Biobank)
N=100 will be selected for inclusion in the current ERA-
NET Project
50 schizophrenia at early stage
50 schizophrenia at later stage
ANIMAL STUDY: MIA MODEL
Pregnant Long-Evans rats
Vehicle (N=5) or Poly (N=15)
x 2 experiments
OFFSPRING
ADOLESCENT – BIOCHEMISTRY COHORT
(20 controls; 60 Poly: 50% each sex)
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Blood samples: 1.5 ml
1 ml blood for
epigenetics
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ADOLESCENT – ADULT BEHAVIOUR COHORT






Rats will have free access to food (3 days) and two 
bottles of tap water and solution with saccharin 
Snaith-Hamilton Pleasure Scale (SHAPS)




1 session of social interaction with 2 pairs of non-
siblings with same-sex rats
Social Adaptation Self-Evaluation Social Scale 
(SASS)





Habituation trial (1 session) + Training (3 
consecutive days ) + Test trial
CANTAB Cognitive battery
Spatial Working Memory (SWM): visuospatial WM
RTI (processing speed), PAL (visual M), OTS 
(Executive f.), MTT (set-shifting), RVP (attention), 




PPI of the acoustic startle reflex
SDI-lab system (1 session)
Two standard startle chambers (SR-LAB)
PPI of the acoustic startle reflex
Assessment with a BIOPAC MP160 system
EMG recording (orbicularis oculi muscle)
1
EPIGENETICS
Humans: Blood (Adolescents + Schizophrenia; N= 250)
Genome-wide Methylation
Infinium MethylationEPIC Bead Chip (Illumina): >850.000 CpG loci
Extraction (signal intensities) with Illumina Genome Studio + Analyses with R and Chip Analysis
Methylation Pipeline
Supplementary Quality Check
Rats: Blood and brain (N= 80)
Reduced Representation Bisulfite Sequencing (RRBS)
Methylation of > 2 million CpG




Humans: Plasma (Adolescents + Schizophrenia; N= 250)
Rats: Blood and brain (N=80)
Pipeline developed in the laboratory of Mathias Mann
Highly reproducible and quantitative high-throughput information of 100s to 1000s of proteins
Measurement with Liquid Chromatography-Mass Spectrometry (LC-MS)
Analyses with MaxQuant software
Peptide lists searched against Uniprot FASTA database
3
Cost and complexity of determination much higher in brain samples
Planning: first running pilot analyses in plasma and brain and decide analyses (global vs targetted)
If technique works fine for all samples, priorize selection of samples based on available budget and/or
request additional funds if necessary in other calls
Machine Learning
Exploratory machine learning approach for the identification of psychotic-related subtypes
considering behavioural data and ‘omics’ (genomic, epigenetic and proteomics) biomarkers
Two waves of analyses: 1) Behavioural data (second year Project); 2) ‘Omics’ ± behavioural (end
Project)
Unsupervised and supervised machine learning techniques: Associations Rules, Decisions Trees and 
Random Forest, Neural Networks, Support Vector Machine, Evolutionary Computation, Emergent
Self-Organizing feature Maps (ESOM)
Laboratory of Molecular Neuropharmacology and Bioinformatics (Jesús Giraldo, David Roche)
STATISTICS
Classical statistical approaches
Univariate and multivariate analyses (e.g. ANCOVA, regression analyses).
Study of dimensions and subtypes: Principal Component Analysis (PCA), Cluster Analysis, 
Correspondence Analysis, Multidimensional Scalling
1 2 3
COVID-19 IMPACT ON ADOLESCENT STUDY
Clinical part of the adolescent recruitment stopped due to the COVID-19 situation
(difficult to recruit healthy adolescents in the hospital)
Proposal to include UHR cohorts that are already recruited with biological samples:
1) Paris (Marie-Odile Krebs)
2) Other cohorts – contact with other PIs who might be interested in collaborating.
Ideal to have both plasma and DNA samples in a same cohort. However, it might be considered to 
include different cohorts for replicating analyses. 
CONTINGENCY PLAN

